Overbrook Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-15,000
Closed -$590K – 70
2023
Q2
$590K Hold
15,000
– – 0.14% 40
2023
Q1
$365K Hold
15,000
– – 0.1% 56
2022
Q4
$321K Hold
15,000
– – 0.09% 60
2022
Q3
$269K Hold
15,000
– – 0.08% 64
2022
Q2
$144K Hold
15,000
– – 0.04% 83
2022
Q1
$252K Hold
15,000
– – 0.06% 83
2021
Q4
$251K Hold
15,000
– – 0.05% 89
2021
Q3
$244K Buy
+15,000
New +$163K 0.05% 78
2016
Q4
– Sell
-33,152
Closed -$1.53M – 81
2016
Q3
$1.53M Sell
33,152
-42,500
-56% -$2.4M 0.35% 40
2016
Q2
$3.86M Sell
75,652
-36,477
-33% -$1.81M 0.81% 29
2016
Q1
$4.74M Sell
112,129
-5,678
-5% -$289K 1.02% 23
2015
Q4
$9.25M Hold
117,807
– – 1.61% 18
2015
Q3
$4.77M Buy
117,807
+123
+0.1% +$6.52K 0.74% 26
2015
Q2
$6.13M Buy
117,684
+67,684
+135% +$3.37M 0.93% 22
2015
Q1
$2.33M Buy
+50,000
New +$2.6M 0.38% 39

Overbrook Management's ISEE Position: Q3 2023 in Review

Overbrook Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 15,000 shares — an estimated $590K sold.

Overbrook Management first reported a position in ISEE in Q1 2015 and held it in 15 quarters. The position peaked at $9.25M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Overbrook Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Overbrook Management sold 15,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $590K.
  • Overbrook Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 15 quarters.
  • Overbrook Management's IVERIC bio, Inc. Common Stock position peaked at $9.25M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Overbrook Management's 13F filing for Q3 2023, filed 13 Nov 2023.